Two Comprehensive Models to Accelerate Clinical Research

Elligo’s PatientSelect® and SiteSelect models empower and enable research in diagnostics, drugs, biologics, and devices, in all phases and indications.


Optimizes the intersection of healthcare and research and accelerates clinical trials through:

Early, direct access to known, diverse patients

Our network of networks offers EHR data from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites. We search these known patients — who are pre-vetted for protocol inclusion through HIPAA-compliant identified healthcare data — to determine the best intersection for access to optimize engagement, reduce recruitment costs, and overcome enrollment challenges, streamlining each trial and putting the focus on the patient.

PatientSelect Web Picture

Customized acceleration services that allow research sites to join trials with minimal infrastructure, including:

Enhancing the patient experience and supporting study completion by managing patient and caregiver transportation needs

Strategically attracting, engaging, and observing patients throughout the life cycle of the study to exceed enrollment goals and optimize retention

Managing clinical trial financial processes through automated and customized solutions, allowing sites to focus on patient care and trial execution

Patient Navigator Coordination, Home Trial Services, Telemedicine Remote Patient Care, and Data Management to support decentralized and hybrid trials

Connecting research with healthcare data, retrieving digital copies of EHR files, and highlighting study-specific information with AI to reduce site burden, eliminate human error, and enhance inclusion/exclusion review

Supporting contracts, budgets, and regulatory overview to accelerate study startup

And More…

Customized acceleration services that allow research sites to join trials with minimal infrastructure, including:

And More…


Improves research site performance by offering access to:

Healthcare-First Sites

Conventional Sites With Elligo Support

Study Solutions

  • Primary care physicians, specialists, small hospitals, and other healthcare facilities who wouldn’t otherwise participate in research
  • Fully powered by Elligo’s end-to-end research support for optimal performance and maximum trial acceleration
  • Allow local staff to focus on patient care throughout the trial
  • Protect the integrity of the trusted patient-physician relationship

Traditional research sites enhanced by Elligo services, including Study Placement, Financial Management, and Technology

Study-specific site services such as Patient Travel and Engagement to enhance existing site performance

Elligo’s Areas of Expertise

  • Women’s Health
  • Gastroenterology
  • Urology
  • Internal Medicine/Family Medicine
  • Pulmonology
  • Neurology
  • Nephrology
  • Oncology
  • Rheumatology
  • Psychiatry
  • Dermatology
  • Endocrinology
  • Cardiology
doctor looking at tablet
couple looking at phone

Increase Diversity in Clinical Trials

Historically, Black/African American and Hispanic/Latino research participation hovers around 10%.*

Elligo’s adaptive diverse engagement model offers 26% enrollment diversity by offering clinical research as a care option through healthcare, supporting the trusted patient-physician relationship, and reducing barriers to trial participation.

*Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials. 2021. JAMA Netw Open.

Supportive Technology

Elligo’s state-of-the-art technology platforms provide data management, patient engagement, study conduct, and eSource solutions for research and commercialization success.

A reusable, end-to-end technology platform to source, process, analyze, and distribute patient medical record data at scale.


A complete technology stack providing flexible and agile multitherapeutic and geographic reach in support of study identification, patient engagement, study conduct, eSource, and more.